Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 29 min 19 sec ago

Bioventus Acquires DUROLANE(R) assets from Galderma

Tue, 02/04/2014 - 15:55
DURHAM, N.C.--(Healthcare Sales & Marketing Network)--Bioventus, a leader in active orthopaedic healing, today announced that it has entered into an agreement with Galderma to acquire the International assets for DUROLANE®, a product that helps relieve...
Devices, Orthopaedic, Acquisitions
Bioventus, Galderma, DUROLANE, hyaluronic acid, osteoarthritis

Oculus Innovative Sciences Receives European CE Mark for Use of Microcyn(R) in the Topical Treatment of Mild to Moderate Acne

Tue, 02/04/2014 - 15:51
PETALUMA, Calif., Feb. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today announ...
Devices, Dermatology, Regulatory
Oculus Innovative Sciences, Microcyn, HydroGel

Brent Shafer appointed Chief Executive Officer of Philips North America

Tue, 02/04/2014 - 15:49
ANDOVER, Mass.--(Healthcare Sales & Marketing Network)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Brent Shafer as Chief Executive Officer of Philips North America, the company’s single largest market. In his new role, Mr. Shaf...
Devices, Personnel
Royal Philips

Ellipse Technologies Receives FDA Clearance for Next Generation of Unique Limb Lengthening System

Tue, 02/04/2014 - 15:46
IRVINE, CA--(Healthcare Sales & Marketing Network) - Global medical device company, Ellipse Technologies, Inc., has announced that it has received FDA marketing clearance of the PRECICE® 2 Intramedullary Limb Lengthening System in the United States. T...
Devices, Orthopaedic, FDA
Ellipse Technologies, PRECICE, Intramedullary, Limb Lengthening

Regulus Strengthens Executive Management Team with Addition of David Szekeres as Chief Business Officer and General Counsel

Tue, 02/04/2014 - 15:42
Mr. Szekeres Brings Extensive Strategic and Transactional Deal Experience LA JOLLA, Calif., Feb. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and develop...
Biopharmaceuticals, Personnel
Regulus Therapeutics, microRNA

Chiesi Farmaceutici Completes Acquisition of Cornerstone Therapeutics

Tue, 02/04/2014 - 13:23
PARMA, Italy and CARY, N.C., Feb. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Chiesi Farmaceutici S.p.A. ("Chiesi"), a leading European pharmaceutical company, and Cornerstone Therapeutics Inc. (CRTX) ("Cornerstone"), a specia...
Biopharmaceuticals, Mergers & Acquisitions
Chiesi Farmaceutici, Cornerstone Therapeutics

NeuroMetrix Announces Broad SENSUS Distribution Agreement with DJO Global

Tue, 02/04/2014 - 13:19
WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--NeuroMetrix, Inc. (the “Company”) (NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced a national distribution agreem...
Devices, Distribution
NeuroMetrix, DJO Global, SENSUS Pain Management

LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario(TM) Blood Glucose Monitoring Device in Australia

Tue, 02/04/2014 - 13:14
CAESAREA, Israel, Feb. 4, 2014 -- (Healthcare Sales & Marketing Network) -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes Management Platform, announced today that the company has signed an agreement with uHealth Australia Pty ...
Devices, Monitoring, Endocrinology, Distribution
LabStyle Innovations, Dario, uHealth Australia, blood glucose monitor

Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales

Tue, 02/04/2014 - 13:07
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Amarin Corporation plc (AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, a...
Biopharmaceuticals, Personnel
Amarin, Vascepa, icosapent ethyl, omega-3

Merck Announces Canadian Approval of GRASTEK(R) (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)

Mon, 02/03/2014 - 16:17
GRASTEK (Timothy Grass Pollen Allergen Extract) Remains Under FDA Review in the United States WHITEHOUSE STATION, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, today announced the regulator...
Biopharmaceuticals, Regulatory
Merck, GRASTEK, Phleum pratense, allergy

Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million

Mon, 02/03/2014 - 16:13
LAVAL, Quebec, Feb. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will acquire PreCision Dermat...
Biopharmaceuticals, Dermatology, Mergers & Acquisitions
Valeant Pharmaceuticals, Precision Dermatology

Accellent to Acquire Lake Region Medical

Mon, 02/03/2014 - 16:10
Combining Strengths to Create a Leading Interventional Vascular Business New Enterprise Will Be Called Lake Region Medical WILMINGTON, Mass. & MINNEAPOLIS--(Healthcare Sales & Marketing Network)--Today, Accellent Inc., a leading provider of fully in...
Devices, Interventional, Mergers & Acquisitions
Accellent, Lake Region Medical

Neovasc Inc. Announces Successful First Human Implant of Tiara(TM) Transcatheter Mitral Valve

Mon, 02/03/2014 - 16:07
VANCOUVER , Feb. 3, 2014 (Healthcare Sales & Marketing Network) - Neovasc Inc. (NVC.V) today announced that a first-in-human implantation of its Tiara™ transcatheter mitral valve was successfully performed on January 30 th by physicians at St. Paul's Hos...
Devices, Interventional Cardiology
Neovasc , Tiara, transcatheter mitral valve, mitral valve

Medline Acquires Professional Hospital Supply

Mon, 02/03/2014 - 16:04
PHS complements Medline’s fast-growing business MUNDELEIN, Ill.--(Healthcare Sales & Marketing Network)--Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of healthcare products, announced today that it has acqui...
Devices, Distribution, Mergers & Acquisitions
Medline, Professional Hospital Supply

PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration

Mon, 02/03/2014 - 14:06
INCLINE VILLAGE, Nev., Feb. 3, 2014 -- (Healthcare Sales & Marketing Network) -- PDL BioPharma, Inc. (PDL) (PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd. (Roche) which resolves a...
Biopharmaceuticals, Litigation
PDL BioPharma, Genentech, Roche Group, Herceptin, Lucentis, Xolair

Mazor Robotics Sells Second Renaissance System to Westside Surgical Hospital

Mon, 02/03/2014 - 13:57
CAESAREA, Israel--(Healthcare Sales & Marketing Network)--Mazor Robotics Ltd. (MZOR.TA) (NASDAQ GM: MZOR), a developer of innovative guidance systems and complementary products, announced today that it has sold a second Renaissance system to Westside Surgi...
Devices, Surgery
Mazor Robotics, Renaissance system, robotic surgery

Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy

Mon, 02/03/2014 - 13:48
PillCam COLON is the Only Non-Invasive and Radiation-Free Solution for the Approximately 750,000 Patients in the U.S. Who Experience an Incomplete Colonoscopy Each Year The Company's PillCam COLON Has a Global Market Opportunity of 3 Million Procedures ...
Devices, Gastroenterology, FDA
Given Imaging, PillCam COLON, capsule endoscopy

Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India

Mon, 02/03/2014 - 13:40
Availability of 150 mg formulation increases dosing convenience and flexibility MUMBAI and PITTSBURGH, Feb. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL), one of the world's leading generic and specialty pharmaceutical companies...
Biopharmaceuticals, Product Launch
Mylan, trastuzumab, Hertraz, biosimilar, breast cancer

Forest Laboratories, Inc. Files Lawsuit Against Several Companies for Infringement of NAMENDA XR(R) Patents

Sun, 02/02/2014 - 16:20
NEW YORK--(Healthcare Sales & Marketing Network)--Forest Laboratories, Inc. (FRX) and Forest Laboratories Holdings, Ltd. (collectively, “Forest”) announced that Forest, Merz Pharma GmbH & Co. KgaA (“Merz”) and Adamas Pharmaceuticals, Inc. (“Adamas”) have j...
Biopharmaceuticals, Neurology, Generics, Litigation
Forest Laboratories, Sun Pharma, Teva Pharmaceutical, NAMENDA XR

Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit

Fri, 01/31/2014 - 17:14
INDIANAPOLIS, Jan. 31, 2014 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) has provided the following statement regarding a lawsuit filed by Sanofi in the United States District Court for the District of Delaware alleging patent ...
Biopharmaceuticals, Endocrinology, Litigation
Eli Lilly, Sanofi, LY2963016, insulin glargine, diabetes

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong